New Anticoagulants: A well-dosed introduction

New anticoagulation medications for patients with (risk of) thrombosis must be introduced under certain conditions. The new medications have great advantages for patients and the results of clinical studies into the safety and effectiveness of this appear to be promising. But now the question is whether they also yield more health benefits compared to current medications, for acceptable costs. This is what the Health Council writes in an advisory report to the Minister of Health, Welfare and Sport.

Committee

• Prof. dr. E. Briët, Emeritus Professor of Internal Medicine, Amsterdam, Chairman
• Prof. dr. A. Algra, Professor in the Clinical Epidemiology of Thrombosis Treatment and Prevention, University Medical Centre Utrecht and Leiden University Medical Centre
• Prof. dr. Ph.G. de Groot, Professor in Thrombosis and Haemostasis, University Medical Centre Utrecht
• H. van Laarhoven, De Hart & Vaatgroep, The Hague
• Dr. K. Meijer, Haematologist, University Medical Centre Groningen
• Prof. dr. J.C.M. Meijers, Professor in Experimental Vascular Medicine, Academic Medical Centre Amsterdam
• Prof. dr. S. Middeldorp, Professor in Internal Medicine, in Particular Thrombosis and Haemostasis, Academic Medical Centre Amsterdam
• Dr. K. Redekop, Clinical Epidemiologist and Health Economist, Erasmus University Rotterdam
• Prof. dr. P. H. Reitsma, Professor in Experimental Molecular Medicine, Leiden University Medical Centre
• Prof. dr. P.A.B.M. Smits, Professor in Pharmacology, University Medical Centre St. Radboud, Nijmegen
• Prof. dr. H.J.G.M. Crijns, Professor in Cardiology, University Medical Centre Maastricht, advisor
• Prof. dr. A.W. Hoes, Professor in Clinical Epidemiology/General Practice, University Medical Centre Utrecht, advisor
• Prof. dr. F.W.G. Leebeek, Special Professor in Haematology, in Particular Haemostasis and Thrombosis, Erasmus Medical Centre, advisor
• Dr. F.J.M. van der Meer, Specialist in Internal Medicine, Leiden University Medical Centre, advisor
• Prof. dr. M.J. Postma, Professor in Pharmacy/Health Economist, Rijksuniversiteit Groningen, advisor
• Drs. P.P. Kruger, Ministry of Health, Welfare and Sport, The Hague, observer
• Dr. P.M. Engelfriet, Health Council, The Hague, scientific secretary
• Dr. C.A. Postema, Health Council, The Hague, scientific secretary